Skip to main content
رجوع
COO logo

The Cooper Companies, Inc.

جودة البيانات: 100%
ذروة بيع
COO
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 70.49
▲ KWD 0.25 (0.36%)
القيمة السوقية: 13.75B
نطاق اليوم
KWD 69.17 KWD 71.33
نطاق 52 أسبوعًا
KWD 61.78 KWD 89.83
حجم التداول
1,230,184
متوسط 50 يوم / 200 يوم
KWD 80.00 / KWD 74.62
الإغلاق السابق
KWD 70.24

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 36.7 0.3
P/B 1.7 2.9
ROE % 4.6 3.7
Net Margin % 9.2 3.8
Rev Growth 5Y % 8.8 10.0
D/E 0.3 0.2

السعر المستهدف للمحللين

Hold
KWD 93.860 +33.2%
Low: KWD 73.000 High: KWD 100.000
مكرر الربحية المستقبلي
15.2
ربحية السهم المستقبلية
KWD 4.620
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
4.3 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 5.964
KWD 5.902 – KWD 6.018
5 B 2
FY2028 KWD 5.453
KWD 4.889 – KWD 6.179
4.8 B 6
FY2027 KWD 5.030
KWD 4.879 – KWD 5.111
4.5 B 12

النقاط الرئيسية

Revenue grew 8.78% annually over 5 years — modest growth
ROE of 4.59% is below average
Debt/Equity of 0.34 — conservative balance sheet
Generating 433.70M in free cash flow
P/E of 36.69 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.72%

النمو

Revenue Growth (5Y)
8.78%
Revenue (1Y)5.06%
Earnings (1Y)-4.44%
FCF Growth (3Y)42.03%

الجودة

Return on Equity
4.59%
ROIC4.65%
Net Margin9.16%
Op. Margin16.69%

الأمان

Debt / Equity
0.34
Current Ratio1.89
Interest Coverage6.83

التقييم

P/E Ratio
36.69
P/B Ratio1.67
EV/EBITDA24.05
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.06% Revenue Growth (3Y) 6.72%
Earnings Growth (1Y) -4.44% Earnings Growth (3Y) 12.89%
Revenue Growth (5Y) 8.78% Earnings Growth (5Y) -40.27%
Profitability
Revenue (TTM) 4.09B Net Income (TTM) 374.90M
ROE 4.59% ROA 3.02%
Gross Margin 60.67% Operating Margin 16.69%
Net Margin 9.16% Free Cash Flow (TTM) 433.70M
ROIC 4.65% FCF Growth (3Y) 42.03%
Safety
Debt / Equity 0.34 Current Ratio 1.89
Interest Coverage 6.83 Dividend Yield 0.00%
Valuation
P/E Ratio 36.69 P/B Ratio 1.67
P/S Ratio 3.36 PEG Ratio -8.16
EV/EBITDA 24.05 Dividend Yield 0.00%
Market Cap 13.75B Enterprise Value 16.43B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.09B 3.90B 3.59B 3.31B 2.92B
Net Income 374.90M 392.30M 294.20M 385.80M 2.94B
EPS (Diluted) 1.87 1.96 1.48 1.94 59.07
Gross Profit 2.48B 2.60B 2.36B 2.14B 1.96B
Operating Income 682.90M 705.70M 533.10M 507.60M 505.80M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.39B 12.32B 11.66B 11.49B 9.61B
Total Liabilities 4.16B 4.23B 4.11B 4.32B 2.66B
Shareholders' Equity 8.24B 8.08B 7.55B 7.17B 6.94B
Total Debt 2.78B 2.58B 2.57B 2.76B 1.48B
Cash & Equivalents 110.60M 107.60M 120.80M 138.20M 95.90M
Current Assets 2.11B 1.95B 1.70B 1.53B 1.47B
Current Liabilities 1.11B 1.02B 969.00M 1.28B 732.10M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#1000 of 1052
18

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026